Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19228532 | 1.00 | CYP2C19 (0.53) | CYP2C19CYP2D6CYP1A2CYP3A4CYP2C9 | |
| Water SCHEMBL27452260 | 0.98 | CYP2C19 (0.52) | CYP2C19CYP2D6CYP1A2CYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL16401889 | 0.98 | CYP2C19 (0.52) | CYP2C19CYP2D6CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL455432 | 0.88 | POLB (0.53) | CYP2C19LMNAHSD17B10SMN1; SMN2MAPK1 | |
| SCHEMBL10547787 | 0.87 | CYP2C19 (0.46) | CYP2C19CYP2D6CYP1A2CYP3A4CYP2C9 | |
| SCHEMBL30371912 | 0.87 | CYP2C19 (0.61) | CYP2C19CYP2D6LMNASRCSMN1; SMN2 | |
| SCHEMBL4444443 | 0.86 | TBXAS1 (0.51) | CYP2C19LMNAPOLBTBXAS1MME | |
| SCHEMBL1911433 | 0.86 | TBXAS1 (0.51) | CYP2C19LMNAPOLBTBXAS1MME | |
| SCHEMBL27541113 | 0.86 | POLB (0.51) | CYP2C19LMNAHSD17B10SMN1; SMN2MAPK1 | |
| SCHEMBL6728896 | 0.86 | CYP2C19 (0.49) | CYP2C19CYP2D6CYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119507208-A | Preparation method of soft hydrophobic fabric | 广东群豪服饰有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-118958076-A | Artificial lawn and preparation method thereof | 江苏共创人造草坪股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| US-20240269066-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING XEROPHTHALMIA | PRECVISION BIOTECHNOLOGIES LTD. (CN) | 2024-08-15 | — | — | US | claimed |
| CN-116060124-B | Oil-soluble organic metal salt composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-117925426-A | Rhodotorula mucilaginosa (Rhodotorula mucilaginosa) strain 147 and application, product and method thereof | 宁夏农产品质量标准与检测技术研究所(宁夏农产品质量监测中心) | 2024-04-26 | — | — | CN | claimed |
| EP-4353264-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING DRY EYE SYNDROME | Precvision Biotechnologies Ltd. (CN) | 2024-04-17 | — | — | EP | claimed |
| CN-114315636-B | Synthesis method of 1-propyl- [4- (4' -butylphenylazo) ] azobenzene | 烟台丰鲁精细化工有限责任公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117004344-A | Carboxyl styrene-butadiene latex for lithium battery cathode and preparation method thereof | 淄博奥固特科技有限公司 | 2023-11-07 | — | — | CN | claimed |
| CN-116165095-A | Method and equipment for rapidly detecting solid content of carboxyl styrene-butadiene latex | 河北昊泽化工有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-116060124-A | Oil-soluble organic metal salt composition and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| US-20050267168-A1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2005-12-01 | — | — | US | claimed |
| CN-1200703-C | Use of pentanoate derivant | ONO PHARMACEUTICAL CO (JP) | 2005-05-11 | — | — | CN | claimed |
| US-20030096802-A1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2003-05-22 | — | — | US | claimed |
| CN-1322524-A | Use of pentanoate derivant | ONO PHARMACEUTICAL CO (JP) | 2001-11-21 | — | — | CN | claimed |
| US-6201021-B1 | TREATMENT OF DISEASES INDUCED BY REACTIVE ASTROCYTES | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-03-13 | — | — | US | claimed |
| EP-0632008-B1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO (JP) | 1998-02-04 | — | — | EP | claimed |
| CN-1100408-A | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO (JP) | 1995-03-22 | — | — | CN | claimed |
| EP-0632008-A1 | Pentanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-01-04 | — | — | EP | claimed |
| US-5190946-A | Piperazine compounds restore sensitivity to drug resistant cancer cells | HOFFMANN-LA ROCHE INC. (US) | 1993-03-02 | — | — | US | claimed |
| EP-0443569-A2 | Diamine derivatives and their use in oncology | F. HOFFMANN-LA ROCHE AG (CH) | 1991-08-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050267168-A1 | Pentanoic acid derivatives | FFAR3, FFAR1, HCAR3 | CYP2C19 1586/4885CYP2D6 1818/4885CYP1A2 3287/4885 |
| US-20030096802-A1 | Pentanoic acid derivatives | FFAR3, FPR1, FPR3 | CYP2C19 3633/4885CYP2D6 1720/4885CYP1A2 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.